James D Chalmers 个人学术档案

引用次数

	总计	2019 年至今
引用	31758	23779
h 指数	90	74
i10 指数	318	294

6000

3000

1500

4500

200920102011201220132014201520162017201820192020202120222023202494 105 244 399 535 677 871 1193 1389 2041 2308 2597 4337 5512 5683 3205

开放获取的出版物数量

查看全部

194 篇文章

22 篇文章

可查看的文章

无法查看的文章

根据资助方的强制性开放获取政策

合著作者

Stefano AlibertiHumanitas University, Milan, Italy在 hunimed.eu 的电子邮件经过验证
Prof. Adam HillUniversity of Edinburgh在 nhs.net 的电子邮件经过验证
Anthony De SoyzaProfessor, Newcastle University UK在 ncl.ac.uk 的电子邮件经过验证
Aran SinganayagamImperial College London在 imperial.ac.uk 的电子邮件经过验证
Michael LoebingerConsultant Respiratory Medicine, Royal Brompton Hospital在 rbht.nhs.uk 的电子邮件经过验证
Oriol SibilaHospital Clinic - IDIBAPS在 clinic.cat 的电子邮件经过验证
J Stuart ElbornImperial College and Royal Brompton Hospital, London在 imperial.ac.uk 的电子邮件经过验证
Amelia ShoemarkAsthma and Lung UK/GSK Chair of Respiratory Research, University of Dundee and Royal Brompton在 rbht.nhs.uk 的电子邮件经过验证
Charles HaworthRoyal Papworth Hospital & University of Cambridge, Cambridge, UK在 nhs.net 的电子邮件经过验证
Francesco Bruno BLASIUNIVERSITA' DEGLI STUDI DI MILANO在 unimi.it 的电子邮件经过验证
Michal ShteinbergDirector- bronchiectasis and adult CF service, Pulmonology Institute and CF Center Carmel Medical Center, Haifa, Israel; Technion- Israel Institute of Tehcnology, B. Rappaport Faculty of Medicine在 technion.ac.il 的电子邮件经过验证
Ahsan AkramUniversity of Edinburgh/Department of Respiratory Medicine在 ed.ac.uk 的电子邮件经过验证
Marcos I RestrepoSouth Texas Veterans Health Care System - University of Texas Health San Antonio在 uthscsa.edu 的电子邮件经过验证
Felix C. RingshausenProfessor of Respiratory Medicine, Hannover Medical School, German Center for Lung Research在 mh-hannover.de 的电子邮件经过验证
Jeffrey T.-J. HuangSystems Medicine, School of Medicine, University of Dundee在 dundee.ac.uk 的电子邮件经过验证
Philip M ShortClinical Lecturer in Respiratory Medicine , University of Dundee在 dundee.ac.uk 的电子邮件经过验证
Giovanni SotgiuUniversity of Sassari在 uniss.it 的电子邮件经过验证
Josje AltenburgPulmonologist, MD, PhD - Amsterdam UMC The Netherlands在 amsterdamumc.nl 的电子邮件经过验证
Micheál Mac AogáinBiochemical Genetics Laboratory - St James's Hospital在 stjames.ie 的电子邮件经过验证
Gisli EinarssonQueen's University Belfast在 qub.ac.uk 的电子邮件经过验证

关注

James D Chalmers

Asthma and Lung UK Chair of Respiratory Research, University of Dundee

在 dundee.ac.uk 的电子邮件经过验证 - 首页

Respiratory infections pneumonia bronchiectasis COPD


标题按引用次数排序按年份排序按标题排序	引用次数引用次数	年份
" Integrative Microbiomics" Through Similarity Network Fusion Identifies Clinically Relevant Bronchiectasis Phenotypes M Mac Aogáin, JN Kumar, AYH Lim, TB Low, TH Ong, FT Chew, B Oliver, ... D97. FUNGAL INFECTIONS: FROM BENCH TO BEDSIDE, A7064-A7064, 2019		2019
“Integrative microbiomics” reveals a disrupted interactome in bronchiectasis exacerbations JK Narayana, M Mac Aogáin, PY Tiew, NABM Ali, AYH Lim, H Keir, ... European Respiratory Journal 56 (suppl 64), 2020		2020
“The missing ingredient”: the patient perspective of health related quality of life in bronchiectasis: a qualitative study EK Dudgeon, M Crichton, JD Chalmers BMC pulmonary medicine 18, 1-10, 2018	42	2018
1. Division of Molecular and Clinical Medicine, Ninewells Hospital and Medical School, Dundee, DD1 9SY, UK. M Barbosa, JD Chalmers
10 years since TORCH: shining a new light on the risks of inhaled corticosteroids in COPD JD Chalmers, HR Keir European Respiratory Journal 50 (3), 2017	12	2017
1Population Health Sciences, Life Sciences and Medicine, King’s College London, UK 2School of Medicine, University of Dundee, Dundee, UK Corresponding author: Dr Arietta Spinou … A Spinou, JD Chalmers
A 2× 2 factorial, randomised, open-label trial to determine the clinical and cost-effectiveness of hypertonic saline (HTS 6%) and carbocisteine for airway clearance versus … JM Bradley, R Anand, B O’neill, K Ferguson, M Clarke, M Carroll, ... Trials 20, 1-10, 2019	10	2019
A BEAT-PCD consensus statement: a core outcome set for pulmonary disease interventions in primary ciliary dyskinesia R Kos, M Goutaki, HE Kobbernagel, B Rubbo, A Shoemark, S Aliberti, ... ERJ open research 10 (1), 2024		2024
A Bispecific Monoclonal Antibody Targeting Psl and PcrV Enhances Bronchiectasis Patient Neutrophil-Mediated Killing of Pseudomonas Aeruginosa MB Long, A Gilmour, M Kehl, D Tabor, ML Crichton, AE Lidwell, H Lind, ... A98. HOST VS. BUG, A2522-A2522, 2023		2023
A Bispecific Monoclonal Antibody Targeting Psl and PcrV Enhances Neutrophil-Mediated Killing of Pseudomonas aeruginosa in Patients with Bronchiectasis MB Long, A Gilmour, M Kehl, D Tabor, AE Keller, P Warrener, ... American Journal of Respiratory and Critical Care Medicine, 2024	2	2024
A broad immunological screening may impact treatment in bronchiectasis patients E Franceschi, B Vigone, G Sotgiu, M Gaffuri, A Gramegna, C Di Francesco, ... European Respiratory Journal 54 (suppl 63), 2019		2019
A cluster analysis of bronchiectasis patients based on the airway immune profile L Perea, E Cantó, G Suarez-Cuartin, S Aliberti, JD Chalmers, O Sibila, ... Chest 159 (5), 1758-1767, 2021	22	2021
A comprehensive analysis of the impact of pseudomonas aeruginosa colonisation in adult bronchiectasis S Finch, T Fardon, M Friel, J Chalmers European Respiratory Journal 46 (suppl 59), 2015		2015
A Comprehensive Analysis of the Impact of Pseudomonas aeruginosa Colonization on Prognosis in Adult Bronchiectasis S Finch, MJ McDonnell, H Abo-Leyah, S Aliberti, JD Chalmers Annals of the American Thoracic Society 12 (11), 1602-1611, 2015	428	2015
A comprehensive approach to lung function in bronchiectasis D Radovanovic, P Santus, F Blasi, G Sotgiu, F D'Arcangelo, E Simonetta, ... Respiratory medicine 145, 120-129, 2018	72	2018
A core outcome set for bronchiectasis in children and adolescents for use in clinical research: an international consensus study AB Chang, J Boyd, A Bush, AT Hill, Z Powell, A Zacharasiewicz, ... The Lancet Respiratory Medicine 12 (1), 78-88, 2024	3	2024
A cuckoo COVID coincidence? JD Chalmers, M Lonergan European Respiratory Journal 56 (4), 2020		2020
A descriptive cohort study of withdrawal from inhaled corticosteroids in COPD patients S Patel, S Dickinson, K Morris, HF Ashdown, JD Chalmers NPJ Primary Care Respiratory Medicine 32 (1), 25, 2022	4	2022
A high-risk airway mycobiome characterises frequent COPD exacerbators PY Tiew, A Dicker, HR Keir, ME Poh, SL Pang, SA Matta, BQY Chua, H Xu, ... European Respiratory Journal 56 (suppl 64), 2020	1	2020
A high-risk airway mycobiome is associated with frequent exacerbation and mortality in COPD PY Tiew, AJ Dicker, HR Keir, ME Poh, SL Pang, M Mac Aogáin, ... European Respiratory Journal 57 (3), 2021	59	2021

系统目前无法执行此操作，请稍后再试。

文章 1–20

每年引用数

重复的引用

合并的引用

添加合著者合著作者

上传 PDF

关注此作者

引用次数

合著作者

引用